Thomas A. Fitzgerald - Jun 14, 2024 Form 4 Insider Report for Transcode Therapeutics, Inc. (RNAZ)

Role
Interim CEO, CFO, Director
Signature
/s/ Thomas A. Fitzgerald
Stock symbol
RNAZ
Transactions as of
Jun 14, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 04:15 PM
Previous filing
Oct 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAZ Stock Option (right to buy) Award $0 +650K $0.00 650K Jun 14, 2024 Common Stock 650K $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.